Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10636)
All Articles published online
|
Publishing Process of This Article
|
Aug 14, 2016 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lazăr DC, Tăban S, Cornianu M, Faur A, Goldiş A. New advances in targeted gastric cancer treatment. World J Gastroenterol 2016; 22(30): 6776-6799 [PMID: 27570417 DOI: 10.3748/wjg.v22.i30.6776] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v22/i30/6776.htm |
| Number | Citing Articles |
| 1 |
Bibo Tan, Yong Li, Yan Di, Liqiao Fan, Qun Zhao, Qingwei Liu, Dong Wang, Nan Jia. Clinical value of peripheral blood microRNA detection in evaluation of SOX regimen as neoadjuvant chemotherapy for gastric cancer. Journal of Clinical Laboratory Analysis 2018; 32(4) doi: 10.1002/jcla.22363
|
| 2 |
Sabino Russi, Henu Kumar Verma, Simona Laurino, Pellegrino Mazzone, Giovanni Storto, Anna Nardelli, Pietro Zoppoli, Giovanni Calice, Francesco La Rocca, Alessandro Sgambato, Valeria Lucci, Geppino Falco, Vitalba Ruggieri. Adapting and Surviving: Intra and Extra-Cellular Remodeling in Drug-Resistant Gastric Cancer Cells. International Journal of Molecular Sciences 2019; 20(15): 3736 doi: 10.3390/ijms20153736
|
| 3 |
Margarida Espadinha, Valentina Barcherini, Lídia M. Gonçalves, Elies Molins, Alexandra M. M. Antunes, Maria M. M. Santos. Tryptophanol-Derived Oxazolopyrrolidone Lactams as Potential Anticancer Agents against Gastric Adenocarcinoma. Pharmaceuticals 2021; 14(3): 208 doi: 10.3390/ph14030208
|
| 4 |
Muhammad Usman, Aferin Beilerli, Albert Sufianov, Valentin Kudryashov, Tatiana Ilyasova, Pavel Balaev, Andrei Danilov, Hong Lu, Ilgiz Gareev. Investigations into the impact of non-coding RNA on the sensitivity of gastric cancer to radiotherapy. Frontiers in Physiology 2023; 14 doi: 10.3389/fphys.2023.1149821
|
| 5 |
Long Feng, Lei Shao, Shuangshuang Sun, Chengwu Zhang, Baojia Cai. Analysis of the efficacy and influencing factors of preoperative P‐SOX neoadjuvant chemotherapy regimen for progressive gastric cancer—construction of a clinical prediction model. Cancer Medicine 2023; 12(12): 13031 doi: 10.1002/cam4.5977
|
| 6 |
Gretel Terrero, A. Craig Lockhart. Role of Immunotherapy in Advanced Gastroesophageal Cancer. Current Oncology Reports 2020; 22(11) doi: 10.1007/s11912-020-00975-y
|
| 7 |
Fu‐Zhou Yao, De‐Gang Kong. Identification of kinesin family member 3B (KIF3B) as a molecular target for gastric cancer. The Kaohsiung Journal of Medical Sciences 2020; 36(7): 515 doi: 10.1002/kjm2.12206
|
| 8 |
Xiong Shu, Pan-Pan Zhan, Li-Xin Sun, Long Yu, Jun Liu, Li-Chao Sun, Zhi-Hua Yang, Yu-Liang Ran, Yue-Min Sun. BCAT1 Activates PI3K/AKT/mTOR Pathway and Contributes to the Angiogenesis and Tumorigenicity of Gastric Cancer. Frontiers in Cell and Developmental Biology 2021; 9 doi: 10.3389/fcell.2021.659260
|
| 9 |
Amin Talebi Bezmin Abadi. Diagnosis ofHelicobacter pyloriUsing Invasive and Noninvasive Approaches. Journal of Pathogens 2018; 2018: 1 doi: 10.1155/2018/9064952
|
| 10 |
|
| 11 |
Davinder Singh, Divya Dheer, Abhilash Samykutty, Ravi Shankar. Antibody drug conjugates in gastrointestinal cancer: From lab to clinical development. Journal of Controlled Release 2021; 340: 1 doi: 10.1016/j.jconrel.2021.10.006
|
| 12 |
Suheil Albert Atallah-Yunes, Anis John Kadado, Myat Han Soe. Pericardial effusion due to pembrolizumab-induced immunotoxicity: A case report and literature review. Current Problems in Cancer 2019; 43(5): 504 doi: 10.1016/j.currproblcancer.2019.01.001
|
| 13 |
Jing Xu, Xiao Li, Qing Dong, Liyuan Lv, Zhangjun Yun, Li Hou. Shenqi Fuzheng Injection Combined With Chemotherapy for Gastric Cancer: An Overview of Systematic Reviews and Meta-Analyses. Integrative Cancer Therapies 2023; 22 doi: 10.1177/15347354231210811
|
| 14 |
Raj Kumar, Tamanna Islam, Md Nurunnabi. Mucoadhesive carriers for oral drug delivery. Journal of Controlled Release 2022; 351: 504 doi: 10.1016/j.jconrel.2022.09.024
|
| 15 |
Hong-Jun Fei, Song-Chang Chen, Jun-Yu Zhang, Shu-Yuan Li, Lan-Lan Zhang, Yi-Yao Chen, Chun-Xin Chang, Chen-Ming Xu. Identification of significant biomarkers and pathways associated with gastric carcinogenesis by whole genome-wide expression profiling analysis. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4243
|
| 16 |
Gleyce S. Barbosa-Jobim, Évelyn Costa-Lira, Ana Carolina L. Ralph, Luciana Gregório, Telma L.G. Lemos, Rommel R. Burbano, Danielle Q. Calcagno, Marília A.C. Smith, Raquel C. Montenegro, Marne C. Vasconcellos. Biflorin inhibits the proliferation of gastric cancer cells by decreasing MYC expression. Toxicology in Vitro 2020; 63: 104735 doi: 10.1016/j.tiv.2019.104735
|
| 17 |
Lin Li, Zhen Dong, Pengfei Shi, Li Tan, Jie Xu, Pan Huang, Zhongze Wang, Hongjuan Cui, Liqun Yang. Bruceine D inhibits Cell Proliferation Through Downregulating LINC01667/MicroRNA-138-5p/Cyclin E1 Axis in Gastric Cancer. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.584960
|
| 18 |
Bowen Ding, Xujie Gao, Hui Li, Liren Liu, Xishan Hao. A novel microRNA signature predicts survival in stomach adenocarcinoma. Oncotarget 2017; 8(17): 28144 doi: 10.18632/oncotarget.15961
|
| 19 |
Agnieszka Gornowicz, Wojciech Szymanowski, Krzysztof Bielawski, Zbigniew Kałuża, Olga Michalak, Anna Bielawska. Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells. Molecules 2021; 26(21): 6504 doi: 10.3390/molecules26216504
|
| 20 |
晖 李. Identification and Validation of SNP-Containing Genes with Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis. Advances in Clinical Medicine 2020; 10(11): 2832 doi: 10.12677/ACM.2020.1011430
|
| 21 |
Ramon Andrade De Mello, Luis Castelo-Branco, Pedro Castelo-Branco, Daniel Humberto Pozza, Louis Vermeulen, Sofia Palacio, Matthew Salzberg, A. Craig Lockhart. What Will We Expect From Novel Therapies to Esophageal and Gastric Malignancies?. American Society of Clinical Oncology Educational Book 2018; (38): 249 doi: 10.1200/EDBK_198805
|
| 22 |
Jinyan Zhao, Weilan Lan, Jun Peng, Bin Guan, Jie Liu, Min Zhang, Zhixue Zhan, Jiumao Lin, Daniela Russo. Babao Dan Reverses Multiple-Drug Resistance in Gastric Cancer Cells via Triggering Apoptosis and Autophagy and Inhibiting PI3K/AKT/mTOR Signaling. Evidence-Based Complementary and Alternative Medicine 2021; 2021: 1 doi: 10.1155/2021/5631942
|
| 23 |
Huan Wang, Baomin Zhang. The Impact of Transcriptional Profiling Cadherin Family and Therapeutic Approaches of Gastric Cancer: A Translational Outlook on Multi-omics Data Analysis. Applied Biochemistry and Biotechnology 2024; doi: 10.1007/s12010-024-04926-2
|
| 24 |
Laure Brigitte Kouitcheu Mabeku, Mohamadou Bello Epesse, Stephane Fotsing, Roland Kamgang, Magloire Tchidjo. Stool Antigen Testing, a Reliable Noninvasive Method of Assessment of Helicobacter pylori Infection Among Patients with Gastro-duodenal Disorders in Cameroon. Digestive Diseases and Sciences 2021; 66(2): 511 doi: 10.1007/s10620-020-06219-0
|
| 25 |
Jiao Xu, Jin Gong, Mengyang Li, Ye Kang, Jinrong Ma, Xi Wang, Xiao Liang, Xin Qi, Bixin Yu, Jin Yang. Gastric cancer patient-derived organoids model for the therapeutic drug screening. Biochimica et Biophysica Acta (BBA) - General Subjects 2024; 1868(4): 130566 doi: 10.1016/j.bbagen.2024.130566
|
| 26 |
Rupeng Zhang, Yuenan Guo, Zhenchi Ma, Gang Ma, Qiang Xue, Fangxuan Li, Liren Liu. Long non-coding RNA PTENP1 functions as a ceRNA to modulate PTEN level by decoying miR-106b and miR-93 in gastric cancer. Oncotarget 2017; 8(16): 26079 doi: 10.18632/oncotarget.15317
|
| 27 |
Matthias Dottermusch, Sandra Krüger, Hans-Michael Behrens, Christine Halske, Christoph Röcken. Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study. Virchows Archiv 2019; 475(5): 563 doi: 10.1007/s00428-019-02624-7
|
| 28 |
Fengyu Cao, Yongbin Zheng, Chao Yang, Suoyang Huang, Xiaobo He, Shilun Tong, Osamah Ibrahim Khalaf. +HOXA10-AS Promotes Malignant Phenotypes of Gastric Cancer via Upregulating HOXA10. Computational and Mathematical Methods in Medicine 2022; 2022: 1 doi: 10.1155/2022/1846687
|
| 29 |
Na Liang, Chunming Li, Neng Zhang, Qiang Xu, Shengnan Zou, Meng Zhang, Shuyao Si, Li Zeng. Effects of NM23 transfection of human gastric carcinoma cells in mice. Open Life Sciences 2023; 18(1) doi: 10.1515/biol-2022-0610
|
| 30 |
Qian Niu, Jiamin Liu, Xiaoxiao Luo, Beibei Su, Xianglin Yuan. Future of targeted therapy for gastrointestinal cancer: Claudin 18.2. Oncology and Translational Medicine 2021; 7(3): 102 doi: 10.1007/s10330-020-0470-0
|
| 31 |
Jie-Fang Gao, Hong Zhang, Jian Lv, Yue-Ying Fan, Dou Feng, Ling Song. Effects of the long and short isoforms of TIPE3 on the growth and metastasis of gastric cancer. Biomedicine & Pharmacotherapy 2020; 124: 109853 doi: 10.1016/j.biopha.2020.109853
|
| 32 |
Lanxin Jiang, Xiaomin Gong, Wangdi Liao, Nonghua Lv, Runwei Yan. Molecular targeted treatment and drug delivery system for gastric cancer. Journal of Cancer Research and Clinical Oncology 2021; 147(4): 973 doi: 10.1007/s00432-021-03520-x
|
| 33 |
Nannan Liu, Yun Wu, Weipeng Cheng, Yuxuan Wu, Liguo Wang, Liwei Zhuang. Identification of novel prognostic biomarkers by integrating multi-omics data in gastric cancer. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08210-y
|
| 34 |
Ruba Al-Abdulla, Laura Perez-Silva, Elisa Lozano, Rocio I.R. Macias, Elisa Herraez, Mar Abad, Nerea Segues, Luis Bujanda, Oscar Briz, Jose J.G. Marin. Sensitizing gastric adenocarcinoma to chemotherapy by pharmacological manipulation of drug transporters. Biochemical Pharmacology 2020; 171: 113682 doi: 10.1016/j.bcp.2019.113682
|
| 35 |
Ping Li, Jianran Hu, Baozhong Shi, Jun Tie. Baicalein enhanced cisplatin sensitivity of gastric cancer cells by inducing cell apoptosis and autophagy via Akt/mTOR and Nrf2/Keap 1 pathway. Biochemical and Biophysical Research Communications 2020; 531(3): 320 doi: 10.1016/j.bbrc.2020.07.045
|
| 36 |
Feng Wang, Dunke Zhang, Jingxin Mao, Xiao-Xue Ke, Rui Zhang, Chao Yin, Ning Gao, Hongjuan Cui. Morusin inhibits cell proliferation and tumor growth by down-regulating c-Myc in human gastric cancer. Oncotarget 2017; 8(34): 57187 doi: 10.18632/oncotarget.19231
|
| 37 |
Quanying Li, Hongna Tang, Fangfang Hu, Changjiang Qin. Knockdown of A‐kinase anchor protein 4 inhibits hypoxia‐induced epithelial‐to‐mesenchymal transition via suppression of the Wnt/β‐catenin pathway in human gastric cancer cells. Journal of Cellular Biochemistry 2018; 119(12): 10013 doi: 10.1002/jcb.27331
|
| 38 |
Yanfeng Li, Guanyu Zhu, Yan Ma, Hongyan Qu. Retracted: lncRNA CCAT1 contributes to the growth and invasion of gastric cancer via targeting miR‐219‐1. Journal of Cellular Biochemistry 2019; 120(12): 19457 doi: 10.1002/jcb.29239
|
| 39 |
Gen Xi, Qingtao Dong, Bo Yang, Desheng Jiao, Shahanavaj Khan. Curcumin's Dose-Dependent Attenuation of Gastric Cancer Cell Progression Via the PI3K Pathway Blockade. Dose-Response 2023; 21(4) doi: 10.1177/15593258231203585
|
| 40 |
可人 杨. Research Progress of TCM Treatment of Gastric Cancer. Advances in Clinical Medicine 2023; 13(12): 20246 doi: 10.12677/ACM.2023.13122850
|
| 41 |
Yinmou Guo, Yumei Wang, Yali Ma, Gongbin Chen, Peiru Yue, Yang Li. Upregulation of lncRNA SUMO1P3 promotes proliferation, invasion and drug resistance in gastric cancer through interacting with the CNBP protein. RSC Advances 2020; 10(10): 6006 doi: 10.1039/C9RA09497K
|
| 42 |
Zhuoqi Zhang, Ming Wen, Jian Guo, Jianwei Shi, Zhiyu Wang, Bibo Tan, Gang Zhang, Xiangkui Zheng, Aimin Zhang. Clinical value of miR-425-5p detection and its association with cell proliferation and apoptosis of gastric cancer. Pathology - Research and Practice 2017; 213(8): 929 doi: 10.1016/j.prp.2017.05.009
|
| 43 |
Mary Lou Affronti, Jennifer Gamboa Jackman, Frances McSherry, James E. Herndon, Elwood C. Massey, Eric Lipp, Annick Desjardins, Henry S. Friedman, Gordana Vlahovic, James Vredenburgh, Katherine B. Peters. Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma. The Oncologist 2018; 23(8): 889 doi: 10.1634/theoncologist.2018-0149
|
| 44 |
Ding Shi, Jinjin Liu. RPS15a Silencing Suppresses Cell Proliferation and Migration of Gastric Cancer. Yonsei Medical Journal 2018; 59(10): 1166 doi: 10.3349/ymj.2018.59.10.1166
|
| 45 |
Min-Seung Gwak, Jong-Min Park. Changing trends in clinico-pathologic characteristics and treatment outcomes in patients with gastric cancer: A single-center, public hospital, retrospective study. Korean Journal of Clinical Oncology 2018; 14(2): 69 doi: 10.14216/kjco.18013
|
| 46 |
Meiqing Zhang, Wei Huang, Dongkai Yuan. Efficacy and safety of Banxia Xiexin Decoction as a complementary treatment for gastric cancer. Medicine 2021; 100(17): e25747 doi: 10.1097/MD.0000000000025747
|
| 47 |
Guo-Liang Zheng, Guo-Jun Zhang, Yan Zhao, Zhi-chao Zheng. Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.901182
|
| 48 |
Yingchun Li, Chenyu Wang, Mengdan Xu, Cuicui Kong, Aibing Qu, Meng Zhang, Zhichao Zheng, Guirong Zhang. Preoperative NLR for predicting survival rate after radical resection combined with adjuvant immunotherapy with CIK and postoperative chemotherapy in gastric cancer. Journal of Cancer Research and Clinical Oncology 2017; 143(5): 861 doi: 10.1007/s00432-016-2330-1
|
| 49 |
Jiawei Yu, Ruheng Hua, Yan Zhang, Ran Tao, Quhui Wang, Qingfeng Ni. DNA hypomethylation promotes invasion and metastasis of gastric cancer cells by regulating the binding of SP1 to the CDCA3 promoter. Journal of Cellular Biochemistry 2020; 121(1): 142 doi: 10.1002/jcb.28993
|
| 50 |
Agnieszka Gornowicz, Wojciech Szymanowski, Robert Czarnomysy, Krzysztof Bielawski, Anna Bielawska, Irina V. Lebedeva. Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy. PLOS ONE 2021; 16(8): e0255585 doi: 10.1371/journal.pone.0255585
|
| 51 |
Liang‐Yu Bie, Dan Li, Yu Mu, Sheng Wang, Bei‐Bei Chen, Hui‐Fang Lyu, Li‐Li Han, Cai‐Yun Nie, Chang‐Cheng Yang, Lin Wang, Chuan‐Chuan Ren, Wei‐Jie Zhang, Ping Guo, Feng Shi, Qing‐Xia Fan, Liu‐Xing Wang, Xiao‐Bing Chen, Su‐Xia Luo. Analysis of cyclin E co‐expression genes reveals nuclear transcription factor Y subunit alpha is an oncogene in gastric cancer. Chronic Diseases and Translational Medicine 2019; 5(1): 44 doi: 10.1016/j.cdtm.2018.07.003
|
| 52 |
Roghayeh Kangarlouei, Shiva Irani, Zahra Noormohammadi, Fereidoon Memari, Reza Mirfakhraie. ANRIL and ANRASSF1 long noncoding RNAs are upregulated in gastric cancer. Journal of Cellular Biochemistry 2019; 120(8): 12544 doi: 10.1002/jcb.28520
|
| 53 |
Song Liu, Ying Zhu, Lie‑Wen Lin, Shun‑Kai Ding, Xiao‑Cong Lin, Ke‑Li Zhong, Kai Pan, Yong Dai. The composition and variation of the BCR CDR3s in gastric cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8677
|
| 54 |
Matteo Canale, Andrea Casadei-Gardini, Paola Ulivi, Maria Arechederra, Carmen Berasain, Pier-Luigi Lollini, Maite G. Fernández-Barrena, Matías A. Avila. Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities. International Journal of Molecular Sciences 2020; 21(15): 5500 doi: 10.3390/ijms21155500
|
| 55 |
Jie Liu, Lanyu Liu, Jin-Xiang Wan, Ying Song. Long noncoding RNA SNHG20 promotes gastric cancer progression by inhibiting p21 expression and regulating the GSK-3β/ β-catenin signaling pathway. Oncotarget 2017; 8(46): 80700 doi: 10.18632/oncotarget.20959
|
| 56 |
Hui Li, Jing Guo, Guang Cheng, Yucheng Wei, Shihai Liu, Yaoyue Qi, Gongjun Wang, Ruoxi Xiao, Weiwei Qi, Wensheng Qiu. Identification and Validation of SNP-Containing Genes With Prognostic Value in Gastric Cancer via Integrated Bioinformatics Analysis. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.564296
|
| 57 |
Yongjun Zhang, Shuguang Guo, Jian Fang, Bojian Peng, Yuan Zhang, Tiansheng Cao. Tanshinone IIA inhibits cell proliferation and tumor growth by downregulating STAT3 in human gastric cancer. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.6562
|
| 58 |
Shaopeng Sun, Jiajia Chen, Chunyan Weng, Yifan Lu, Chang Cai, Bin Lv. Identification of AKIRIN2 as a potential biomarker and correlation with immunotherapy in gastric adenocarcinoma by integrated bioinformatics analysis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-12531-8
|
| 59 |
Josefina Atrisco-Morales, Verónica I. Martínez-Santos, Adolfo Román-Román, Judit Alarcón-Millán, José De Sampedro-Reyes, Iván Cruz-del Carmen, Dinorah N. Martínez-Carrillo, Gloria Fernández-Tilapa.
vacA s1m1 genotype and cagA EPIYA-ABC pattern are predominant among Helicobacter pylori strains isolated from Mexican patients with chronic gastritis.
Journal of Medical Microbiology
2018; 67(3): 314 doi: 10.1099/jmm.0.000660
|
| 60 |
Qi Shao, Zhi-Ming Chen. Feedback regulation between phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 and transforming growth factor β1 and prognostic value in gastric cancer. World Journal of Gastroenterology 2020; 26(1): 21-34 doi: 10.3748/wjg.v26.i1.21
|
| 61 |
Patrícia Carneiro, Ana Margarida Moreira, Joana Figueiredo, Rita Barros, Patrícia Oliveira, Maria Sofia Fernandes, Anabela Ferro, Raquel Almeida, Carla Oliveira, Fátima Carneiro, Fernando Schmitt, Joana Paredes, Sérgia Velho, Raquel Seruca. S100P is a molecular determinant of E-cadherin function in gastric cancer. Cell Communication and Signaling 2019; 17(1) doi: 10.1186/s12964-019-0465-9
|